GeneDx Holdings Corp. (NASDAQ:WGS) is among the greatest digital well being shares to purchase now.
On October 29, 2025, Guggenheim lifted GeneDx (NASDAQ:WGS) to a $170 value goal (Purchase) after the corporate’s blow-out Q3 announcement a day earlier. GeneDx had simply reported income of $116.7 million, up 52% yr over yr and roughly ~12% above Avenue; exome and genome income reached $98.9 million, up 65%, with exome/genome take a look at volumes up 33%. Gross profitability widened too: adjusted gross margin improved to 74% (GAAP 72%), and adjusted web earnings rose to $14.7 million.
Tonhom1009/Shutterstock.com
That print underpins Guggenheim’s call-outs, with exome and genome volumes nonetheless compounding, ASPs working larger, and gross margin trending up, therefore the larger goal. Administration additionally raised full-year 2025 steering to $425–$428 million in income and 53–55% development in exome/genome income, alongside a 70–71% adjusted gross-margin information.
Crucially, Guggenheim addressed the 2026 spend feedback: even with stepping up opex subsequent yr, the agency doesn’t learn that as a return to adverse EPS, framing it as a substitute as funding in opposition to a now-proven scale curve in pediatric and rare-disease genomics.
GeneDx Holdings Corp. (NASDAQ:WGS) makes a speciality of genomic testing, with a concentrate on whole-exome and whole-genome sequencing for pediatric and uncommon problems. Its choices additionally embody information options that assist scientific decision-making and precision drugs.
Whereas we acknowledge the potential of WGS as an funding, we imagine sure AI shares supply better upside potential and carry much less draw back danger. In the event you’re in search of a particularly undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring development, see our free report on the greatest short-term AI inventory.
READ NEXT: 30 Shares That Ought to Double in 3 Years and 11 Hidden AI Shares to Purchase Proper Now.
Disclosure: None.
